ISDA

Entry Detail

PDB ID:

4W9F

Keywords:

Title:

pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 5)

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli BL21(DE3)

PDB Version:

Deposition Date:

2014-08-27

Release Date:

2014-09-10

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.10 Å

R-Value Free:

0.22

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 41 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Transcription elongation factor B polypeptide 2
Chain IDs:A, D, G, J
Chain Length:104
Number of Molecules:4
Biological Source:Homo sapiens

UniProt ID:Q15370 Pfam ID:PF00240 EC:2.3.2.B13

Protein Blast

Polymer Type:polypeptide(L)
Description:Transcription elongation factor B polypeptide 1
Chain IDs:B, E, H, K
Chain Length:97
Number of Molecules:4
Biological Source:Homo sapiens

UniProt ID:Q15369 Pfam ID:PF03931 EC:2.3.2.B13

Protein Blast

Polymer Type:polypeptide(L)
Description:Von Hippel-Lindau disease tumor suppressor
Chain IDs:C, F, I, L
Chain Length:162
Number of Molecules:4
Biological Source:Homo sapiens

UniProt ID:P40337 Pfam ID:PF01847, PF17211 EC:2.3.2.B13

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
CAS	A	CYS	modified residue

Ligand Molecules

3JU

Primary Citation

Structure-Guided Design and Optimization of Small Molecules Targeting the Protein-Protein Interaction between the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase and the Hypoxia Inducible Factor (HIF) Alpha Subunit with in Vitro Nanomolar Affinities.

Galdeano, C, Gadd, M.S, Soares, P, Scaffidi, S, Van Molle, I, Birced, I, Hewitt, S, Dias, D.M, Ciulli, A.Show

J.Med.Chem. 57 8657 8663 (2014)

PMID: 25166285 DOI: 10.1021/jm5011258

Abstact

E3 ubiquitin ligases are attractive targets in the ubiquitin-proteasome system, however, the development of small-molecule ligands has been rewarded with limited success. The von Hippel-Lindau protein (pVHL) is the substrate recognition subunit of the VHL E3 ligase that targets HIF-1α for degradation. We recently reported inhibitors of the pVHL:HIF-1α interaction, however they exhibited moderate potency. Herein, we report the design and optimization, guided by X-ray crystal structures, of a ligand series with nanomolar binding affinities.

Legend

Protein

Chemical

Disease

Primary Citation of related structures